메뉴 건너뛰기




Volumn 31, Issue 1, 2010, Pages 108-118

Technical challenges in designing post-marketing eCRFs to address clinical safety and pharmacovigilance needs

(1)  Lu, Zhengwu a  

a NONE   (United States)

Author keywords

CDASH; Electronic case report form; Electronic data capture; MedDRA; Pharmacovigilance; Post marketing study; UADE

Indexed keywords

DECISION MAKING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FINANCIAL MANAGEMENT; HEALTH PRACTITIONER; INFORMATION PROCESSING; MEDICAL LITERATURE; PRACTICE GUIDELINE; REVIEW;

EID: 73249133512     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2009.11.004     Document Type: Review
Times cited : (16)

References (19)
  • 1
    • 62449259659 scopus 로고    scopus 로고
    • The use of electronic data capture tools in clinical trials: web-survey of 259 Canadian trials
    • EI Emam K., Jonker E., Sampson M., Krleža-Jerić K., and Neisa A. The use of electronic data capture tools in clinical trials: web-survey of 259 Canadian trials. J Med Internet Res 11 1 (2009) e8
    • (2009) J Med Internet Res , vol.11 , Issue.1
    • EI Emam, K.1    Jonker, E.2    Sampson, M.3    Krleža-Jerić, K.4    Neisa, A.5
  • 3
    • 73249128697 scopus 로고    scopus 로고
    • Information technology in pharmacovigilance: benefits, challenges, and future directions from industry perspectives
    • Lu Z.W. Information technology in pharmacovigilance: benefits, challenges, and future directions from industry perspectives. Drug Healthc Patient Saf 1 (2009) 35-45
    • (2009) Drug Healthc Patient Saf , vol.1 , pp. 35-45
    • Lu, Z.W.1
  • 4
    • 9644255831 scopus 로고    scopus 로고
    • Potential for conflict of interest in the evaluation of suspected adverse drug reactions - a counterpoint
    • Strom B.L. Potential for conflict of interest in the evaluation of suspected adverse drug reactions - a counterpoint. JAMA 292 21 (2004) 2643-2646
    • (2004) JAMA , vol.292 , Issue.21 , pp. 2643-2646
    • Strom, B.L.1
  • 5
    • 73249140241 scopus 로고    scopus 로고
    • Observational data under the microscope
    • Kubick W.R. Observational data under the microscope. Appl Clin Trials 18 4 (2009) 34-38
    • (2009) Appl Clin Trials , vol.18 , Issue.4 , pp. 34-38
    • Kubick, W.R.1
  • 6
    • 64249133042 scopus 로고    scopus 로고
    • Knowledge innovation and clinical operational excellence
    • Hyveled L., Karpur P., and Nakskov H. Knowledge innovation and clinical operational excellence. Drug Inf J 43 2 (2009) 159-170
    • (2009) Drug Inf J , vol.43 , Issue.2 , pp. 159-170
    • Hyveled, L.1    Karpur, P.2    Nakskov, H.3
  • 10
    • 73249116071 scopus 로고    scopus 로고
    • accessed at http://www.phaseforward.com/products/clinical/edc/coding/. Accessed May 25, 2009
    • Central Coding (2009). http://www.phaseforward.com/products/clinical/edc/coding/ accessed at http://www.phaseforward.com/products/clinical/edc/coding/. Accessed May 25, 2009
    • (2009) Central Coding
  • 11
    • 57549096747 scopus 로고    scopus 로고
    • Adopting electronic medical records in primary care: lessons learned from health information systems implementation experience in seven countries
    • Ludwick D.A., and Doucette J. Adopting electronic medical records in primary care: lessons learned from health information systems implementation experience in seven countries. Int J Med Inform 78 1 (2009) 22-31
    • (2009) Int J Med Inform , vol.78 , Issue.1 , pp. 22-31
    • Ludwick, D.A.1    Doucette, J.2
  • 14
    • 4644260256 scopus 로고    scopus 로고
    • Expecting the unexpected - drug safety, pharmacovigilance, and the prepared mind
    • Trontell A. Expecting the unexpected - drug safety, pharmacovigilance, and the prepared mind. NEJM 351 14 (2004) 1385-1387
    • (2004) NEJM , vol.351 , Issue.14 , pp. 1385-1387
    • Trontell, A.1
  • 15
    • 73249141623 scopus 로고    scopus 로고
    • US Food Drug Administration. CFR, Code of Federal Regulations Title 21: Chapter 1-Department of Health and Human Services, Subchapter D, Drugs for human use. PART 312, INVESTIGATIONAL NEW DRUG APPLICATION, April 2009. Available from: October 22, 2009
    • US Food Drug Administration. CFR - Code of Federal Regulations Title 21: Chapter 1-Department of Health and Human Services, Subchapter D - Drugs for human use. PART 312 - INVESTIGATIONAL NEW DRUG APPLICATION, April 2009. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?f r=312.32. Accessed October 22, 2009.
  • 17
    • 73249131087 scopus 로고    scopus 로고
    • Hyperhar Group, accessed at, Accessed June 10, 2009
    • Hyperhar Group. Moving from EDC to a complete eclinical trial solution, accessed at http://www.ngpharma.com/article/Issue-8/Information-Technology/Moving-fr om-EDC-to-a-complete-eclinical-trial-solution/. Accessed June 10, 2009.
    • Moving from EDC to a complete eclinical trial solution
  • 18
    • 35648972697 scopus 로고    scopus 로고
    • Data standards in clinical research: gaps, overlaps, challenges and future directions
    • Richesson R.L., and Krischer J. Data standards in clinical research: gaps, overlaps, challenges and future directions. J Am Med Inform Assoc 14 6 (2007) 687-696
    • (2007) J Am Med Inform Assoc , vol.14 , Issue.6 , pp. 687-696
    • Richesson, R.L.1    Krischer, J.2
  • 19
    • 73049097242 scopus 로고    scopus 로고
    • Anabase International Corp, accessed at, Accessed June11, 2009
    • Anabase International Corp. A View to the Future, accessed at http://www.ngpharma.com/article/Issue-15/Clinical-Research/A-View-to-the -Future. Accessed June11, 2009.
    • A View to the Future


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.